NatureCell "Clinical Trial Application for Stem Cell Therapy Submitted Under Affiliate Albaio's Name"
[Asia Economy Reporter Minji Lee] Nature Cell clarified on the 10th through a public announcement that "the clinical trial application to the Ministry of Food and Drug Safety in Korea was submitted under the name of Albaio, an affiliate company, not Nature Cell."
Hot Picks Today
!["It Has Now Crossed Borders": No Vaccine or Treatment as Bundibugyo Ebola Variant Spreads [Reading Science]](https://cwcontent.asiae.co.kr/asiaresize/93/2026052019230771274_1779272587.jpg)
"It Has Now Crossed Borders": No Vaccine or Treatment as Bundibugyo Ebola Variant Spreads [Reading Science]
- "Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- "Even With a 90 Million Won Salary and Bonuses, It Doesn’t Feel Like Much"... A Latecomer Rookie Who Beat 70 to 1 Odds [Scientists Are Disappearing] ③
- "Am I Really in the Top 30%?" and "Worried About My Girlfriend in the Bottom 70%"... Buzz Over High Oil Price Relief Fund
- "Who Is Visiting Japan These Days?" The Once-Crowded Tourist Spots Empty Out... What's Happening?
On the same day, the company explained, "We applied for a phase 1/2a clinical trial plan to administer the allogeneic stem cell therapy 'Astrostem-v' to severe patients infected with the novel coronavirus disease (COVID-19)," and added, "We also plan to conduct COVID-19 related clinical trials in the United States."
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
